Leyden Labs Lands €20 Million EIB Investment Facilitated by HERA to Advance Pandemic Preparedness Activities
LUXEMBOURG & LEIDEN, the Netherlands--(BUSINESS WIRE)--The European Investment Bank (EIB) and Dutch clinical-stage biotechnology company Leyden Laboratories B.V. have signed a €20 million financing deal to advance development of the Company's broadly-protective antibodies to defend against seasonal and pandemic viral infections. Leyden Labs' lead program is a pan-influenza nasal spray currently in clinical development (PanFlu), which has the potential to provide first-in-class influenza protection and meaningfully reduce the burden of influenza infection, including in infection from Avian Flu (H5).
The venture debt financing agreement is supported under the European Commission's InvestEU programme and specifically falls under 'HERA Invest.' This €110 million initiative from the European Health Union is meant to address biodefence, pandemic readiness and antimicrobial resistance in Europe, as a top-up to the European Union's InvestEU initiative, funded by the EU4Health programme.
'The COVID-19 pandemic taught us multiple lessons, including that we should strengthen the EU's preparedness and autonomy in key areas like bio sciences,' stated EIB Vice President Robert de Groot. 'With the support of the European Commission, the EIB backs highly innovative EU companies like Leyden Labs with venture debt, enabling them to grow and thrive in Europe. Technological innovations from companies like Leyden Labs are key for European competitiveness and the well-being of our society.'
Hadja Lahbib, Commissioner for Equality, Preparedness and Crisis Management, added: 'Respiratory viruses are common and affect us all, especially the most medically vulnerable. Today's agreement reaffirms our commitment to invest in innovation to strengthen preparedness and protection against respiratory viruses. HERA Invest is a prime example of Europe at the forefront of medical advancements in response to serious threats to health.'
'We are thrilled with this endorsement of our approach and support from HERA and the European Investment Bank. This will accelerate our efforts to provide broad, universal protection against current and future viral outbreaks. We are grateful that HERA and the EIB understand the urgency and significance of investing in initiatives to ensure Europe is prepared for pandemic viruses. This concern is greater than ever given the increasing threat of an avian influenza outbreak,' said Koenraad Wiedhaup, co-founder and CEO of Leyden Labs.
Leyden Labs' product candidates are nasal sprays that administer broadly protective antibodies directly to the respiratory mucosa. Leyden Lab's solutions are designed to work at the earliest moment, before the virus even reaches systemic circulation. Systemically administered vaccines primarily generate systemic protection against viruses, however, this may be a limitation that contributes to suboptimal efficacy. Airborne viruses, including influenza, do not directly enter systemic circulation, but rather, they enter the body through the nose and mouth. The Company's antibodies aim to protect against full viral families, so they keep working even when a virus mutates and evolves. This intranasal strategy also has the potential to benefit people with weakened immune systems because it does not rely on the person to be able to mount an immune response in order to be protective.
The Company's novel approach has the potential to transform the way the healthcare ecosystem thinks about viral prophylaxis, while also providing an innovative solution for use both in times of seasonal outbreaks as well as pandemic emergencies.
HERA's responsibility is to ensure that the EU and Member States are ready to act in the face of cross-border health threats. The €20 million proceeds of this financing will support further development of Leyden Labs' novel, non-vaccine approach to fighting respiratory viruses to contribute to European pandemic preparedness efforts.
Background Information:
Health Emergency Preparedness and Response (HERA). The European Commission's Health Emergency Preparedness and Response Authority (HERA) supports projects that strengthen preparedness and response capacities in the field of health. HERA was established as a direct consequence of the lessons learned from the initial management of the COVID-19 pandemic, to ensure a solid Union response to serious-cross border health threats and secure ready availability and accessibility of medical countermeasures. HERA's responsibility is to ensure that the EU and Member States are ready to act in the face of cross-border health threats, and its mandate covers both the strengthening of preparedness in advance of future emergencies and the implementation of a swift and efficient response once crisis hits.
HERA Invest is a €110 million top-up to the InvestEU programme, funded by the EU4Health programme. It is implemented by the EIB and supports projects that focus on pathogens with pandemic potential, chemical, biological, radiological, nuclear threats, and antimicrobial resistance. Together with HERA, the EIB assesses whether an operation meets HERA Invest's criteria.
The InvestEU programme provides the European Union with crucial long-term funding by leveraging substantial private and public funds in support of a sustainable recovery. It also helps mobilise private investment for EU policy priorities, such as the European Green Deal and the digital transition. InvestEU brings together under one roof the multitude of EU financial instruments previously available to support investment in the European Union, making funding for investment projects in Europe simpler, more efficient and more flexible. The programme consists of three components: the InvestEU Fund, the InvestEU Advisory Hub and the InvestEU Portal. The InvestEU Fund is deployed through implementing partners who will invest in projects using the EU budget guarantee of €26.2 billion. The entire budget guarantee will back the investment projects of the implementing partners, increase their risk-bearing capacity and thus mobilise at least €372 billion in additional investment.
The European Investment Bank (EIB) is the long-term lending institution of the European Union, owned by its Member States. The Netherlands owns a 5,2% share of the EIB. It makes long-term finance available for sound investment in order to contribute towards EU policy goals and national priorities. More than 90% of its activity is in Europe. Over the last ten years, the EIB has made available more than €27 billion in financing for Dutch projects in various sectors, including research & development, sustainable mobility, drinking water, healthcare and SMEs. In 2024 the EIB Group, which also includes the EIB's subsidiary, the European Investment Fund (EIF), made available more than €3 billion for Dutch projects.
Leyden Laboratories B.V. (Leyden Labs), founded in 2020, is a clinical-stage biotechnology company based in the Netherlands. Leyden Labs is working to free people from the threat of respiratory viruses, by leveraging its Mucosal Protection Platform to develop a portfolio of candidates aimed at providing protection against influenza, coronaviruses, and other respiratory viruses through a new class of broadly protective nasal sprays. Leyden Labs is supported by a strong syndicate of investors and ambassadors; VC investors include GV (formerly Google Ventures), Casdin Capital, F-Prime Capital, ClavystBio (a life sciences venture investor established by Temasek), Polaris Partners, Qiming Venture Partners, Invus, SoftBank Vision Fund 2, Byers Capital / Brook Byers and Bluebird Ventures. To learn more, visit www.leydenlabs.com.
CR9114, Leyden Labs' lead product candidate for the PanFlu program, is a human monoclonal antibody that protects against influenza in preclinical models. Leyden Labs holds an exclusive license from Janssen Pharmaceuticals Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to develop and commercialize CR9114.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Eater
14 hours ago
- Eater
Can Good Chocolate Make a Macaroon....Exciting?
I have a tendency to anthropomorphize macaroons: I imagine their pain at being constantly mistaken for their more glamorous relation, the macaron, and suffering eternally by comparison. Where the macaron is delicate and pretty and colorful, its shortcomings obscured by its French pedigree, the macaroon is more commonly regarded as a booby prize, something you eat when you have no other dessert choices during Passover. Made of ground almonds, egg whites, and sugar, the macaroon often includes masses of shredded coconut, which gives it the appearance of a bruleed haystack or a tribble. I'm not much of a macaroon person (or a macaron person, for that matter), but the recipe for chocolate macaroons on the back of Guittard's canister of unsweetened red Dutch- process cocoa powder caught my attention a couple of weeks ago. Mostly because the recipe called for cocoa, almond flour, and confectioner's sugar, three ingredients I was trying to use up in advance of a move, but also because I love Guittard products. Guittard's red cocoa is very dark and very rich, one of the rare unsweetened cocoa powders you can almost eat on its own. (It yields excellent hot chocolate.) If anything could make a macaroon more enticing, I theorized, it was this cocoa. The recipe is pretty much a grocery list plus the instructions to stir and bake, a true one-bowl experience. The most challenging thing about it is separating egg whites from yolks. The former get mixed with almond flour, cocoa, confectioner's sugar, and sweetened shredded coconut, though I only had unsweetened coconut flakes and they worked well enough. The recipe calls for using a teaspoon to portion the macaroon batter onto a baking tray, so I did that, and then baked it for the recommended time, about 15 minutes. The macaroons emerged from the oven looking very much as they did when they went in — baking doesn't expand or puff or otherwise noticeably improve alter their appearance, so there's no great miracle of transformation to behold. The finished macaroons are not, as the above photo attests, particularly attractive. But since I like a homely cookie — lumps and crags often equate with greater flavor — this didn't deter me. What did was the fact that this is still a macaroon, and even the addition of Guittard cocoa powder cannot change that. Macaroons are fine! But they're not really a cookie you can lose yourself in; you're always aware that you're negotiating a mouthful of shredded coconut, which is personally not my thing. That said, these are not bad. They're quite chocolatey and not too sweet, and because they're small they're easy to eat by the handful, should you want to do that. Stored properly, they last for several days at room temperature. They also travel well, and as a cyclist, I'm always looking for treats that meet that criteria. Would I go out of my way to make these again, to track down a canister of Guittard cocoa powder for the purpose of consuming macaroons? No. But they do make a very good way to use up a bunch of ingredients, and sometimes, that's a treat in and of itself. Highlighting the people, products, and trends inspiring how we cook now
Business Insider
18 hours ago
- Business Insider
Memorial Day beer sales fizzled, and one big brand was hit especially hard, Goldman Sachs says
Americans bought less beer for Memorial Day weekend, and one brand fizzled more than the rest. The Dutch beer company Heineken had the "weakest" sales among peer beer brands during the holiday weekend, a Goldman Sachs report published Tuesday said. Goldman surveyed about 50 distributors, who represent 230,000 retail outlets, or about 46% of US outlets that sell alcohol. Distributors reported sales trends for Anheuser-Busch, Molson Coors, Heineken, Samuel Adams, and Modelo's parent company. Goldman's report said sales for the overall beer market were "lackluster and largely fell short of expectations" for a variety of reasons, including inflation, tariffs, and immigration. Goldman said Heineken"underperformed," with 66% of US beer distributors surveyed saying the beer company's volumes were down this holiday compared with last year. Heineken did not respond to a request for comment. In the survey, top names including Bud Light, Corona Extra, and Miller Lite also saw a decline in Memorial Day sales volume compared with last year. ABI, Pacifico, and Twisted Tea were among those that saw sales volume increase year over year. About 55% of distributors indicated that beer trends over the holiday were somewhat or much weaker than last year. They said uncertainty around tariffs and high prices of other household items were hurting consumer spending on beer. Some distributors said young people were choosing to drink liquor or "fancier" drinks instead of beer, citing an overall shift to drinking less alcohol. Describing challenges facing Corona Extra, the report cited one distributor who said recent " immigration policy challenges for the Hispanic population" were resulting in reduced consumption for the brand. A cutback on beer drinking during this year's Memorial Day weekend would align with a wider push toward sobriety. Millennials and Gen Zers have reported drinking less in recent years than prior generations did at their age. Gallup, which tracks self-reported drinking trends in surveys over three-year periods, found that from 2021 to 2023, 62% of 18- to 34-year-olds in the US reported drinking alcohol, down from 72% from 2001 to 2003. In January, the then surgeon general, Vivek Murthy, issued a warning about the link between alcohol and cancer. Stocks of several alcohol manufacturers dipped as much as 4% following the report. Companies worldwide are getting creative with low- and no-alcohol offerings. The legacy beer maker Constellation Brands launched nonalcoholic beer in 2022, while Heineken made the move much earlier in 2017. A variety of startups, including Athletic Brewing, Psychedelic Water, and Cann Social Tonic, have also entered the scene for alcohol-free beer and colorful ready-to-drink mocktails.
Yahoo
20 hours ago
- Yahoo
I tried the UK's newest 'Dutch' roundabout - was it really as confusing as some claim?
It was raining when I took a purple bike and helmet (borrowed from a friend) to the opening of a new £2m, "Dutch-style" roundabout built on an industrial estate in Hemel Hempstead. I had not ridden a bike since I was about 10 years old, so it was a little daunting to put myself in front of traffic on a new road layout. Cyclists similarly inexperienced might also be feel uncertain by the unfamiliar array of black, green, red and white road markings. The roundabout is funded by Active Travel England and the basic premise is that cars and lorries must give way to both cyclists and pedestrians - while cyclists must give way to pedestrians. The layout is markedly different to other roundabouts, which has prompted some criticism they are "confusing". So I had made sure to watch the three-minute CGI explainer video the local council created to help uncertain road users like me. The video warned me to keep an eye out for oncoming cars, despite having priority on my segregated cycle track. The roundabout joins three other Dutch-style ones in operation around the UK - in Cambridge, Sheffield and Chichester. They were first introduced in the Netherlands in the early 1980s and were declared the 'Holy Grail' of traffic safety, according to Dutch News. The country is famed for its cycling culture and infrastructure and, according to Urban Cycling Institute, invests €595m each year in infrastructure linked to bicycles. Since then they also become increasingly common in France, especially Paris, and have no headed over to the Channel. In the UK, council leaders say they will help make life easier for those wanting to cross these roundabouts on foot and on bike, while also helping to manage the speed and flow of traffic. The previous Conservative government cut England's cycling and walking budget by £380m in March 2023, according to Bike Radar - though the current government now announced a £291m funding package this year to create 300 miles of new footpaths and cycle tracks in a sign of the shifting momentum towards pro-cyclist transport. Nonetheless - the approach continues to receive a mixed response. In the UK, campaigners have raised concerns over people being confused by the road markings, and who has right of way, with the BBC reporting that Cambridge's Dutch-style roundabout has seen more collisions in the three years since it was built. And even in the Netherlands, concerns remain about accidents at the supposedly cycle-friendly roundabouts. Road safety advocacy group VVN pointed to research that showed 22.3% of roundabouts in the Netherlands had one or more bicycle accidents, 786 of which were the scene of serious incidents, Dutch News reports. But what's it like tackling the newly minted version on Boundary in Hertfordshire, some 30 miles north-west of London? The video warned me to keep an eye out for oncoming cars, despite having priority on my segregated cycle track. So, how easy is this to follow in practice? After a few false starts, I was off across the brightly coloured green cycle lane - which made it very easy to see where I was going. As I made my way onto the roundabout, a man zipping around it on an e-bike did look a little startled by the new configuration and shouted "it's a bit confusing" at me. The roundabout wasn't too busy when I cycled around it with a few cars and lorries who slowed down when they saw me coming. There were one or two lorries who put their foot down when they saw me on the approach - probably thinking they had the element of speed on their side to out-race me. It seemed that many of them were not too sure about the new road lay-out and being cautious of a young woman in high-vis teetering about. With my own cycle lane, it did feel a bit disorientating to be on the look-out for cars - even though I knew I had priority. But, with no pedestrians on a zebra crossing, a driver who is not familiar with Dutch-style roundabouts may believe they have a right of way – cyclist or not. Deciding not to risk it, I was quite wary of how fast I was going while constantly scanning the area ahead. One of the criticisms in Hemel Hempstead has been the location of the roundabout in an industrial estate not from the M1 turn-off and there didn't seem to be many pedestrians (or cyclists) using the snazzy roundabout when Yahoo News was giving it a test run. Even for an inexperienced cyclist like me, roundabouts like these that give priority to cyclists can ultimately only be a good thing - it quickly began to feel like second-nature and knowing motorists were slowing down ahead of time helped instil a bit more confidence. I can only imagine a more experience cyclist will be overjoyed at knowing they have their own designated lane and the traffic stopping especially for them. But putting one of these roundabouts in a location serving mainly delivery drivers in lorries... well, it does seem like it could have gone elsewhere. But what do some of the locals we met feel about it? David Coulson, 65, who regularly drives across the roundabout, told us he "couldn't believe" the cost of the works. "I wouldn't be surprised if people got killed or injured on it," he said. "I also can't believe they spent this much money. It's right off the M1 - you're not going to get many pushbikes coming off there. "I drive but I also take a walk up here. I don't see much other footfall than myself," said Coulson, originally from New Zealand. "At least it's colourful." Finance manager Fred Theron, 52, works close to the new roundabout and cycles to work from Luton in the summer. He said: "The roundabout before was more dangerous because there are a lot of trucks using the it. "Cycling, you'd have to be in the road coming from Boundary Way and that wasn't the best. Now it's going to take a bit longer having to the cycle around the whole ring but it will be safer." Theron said it would take time for motorists to get used to the new road layout, adding: "Here, when I was walking across, there was a truck coming and I wasn't sure if he was going to stop. "I'm not sure if motorists will know how the cycle aspect works with having to give way. But I do think it's a good initiative and hopefully more people will cycle to work like I do." Lib Dem councillor Adrian England, said he felt "perfectly safe" testing out the roundabout following its opening on Tuesday. "With anything new - especially when you're a cyclist and all you've got is your helmet - you need to look after yourself," he said. Meanwhile Stephen Giles-Medhurst, the executive member for Highways from Herts County Council, said he had a go on a bike and acknowledged it would take "a little bit of getting used to". "We hope to encourage more people to cycle or walk to their places of employment," Giles-Medhurst said. "It's safer, as the pedestrian crossings and cycle path go all the way round it. Vehicles are slowing down, maybe because it's new, but I didn't have any near misses. You can't engineer out someone being stupid."Read more Family pays tribute to cyclist killed in collision by Wiltshire driver (Wiltshire Times) Scared of cycling in London? Here's how to do it safely (The London Standard) World Bicycle Day: How Rome is urging more people to ditch their cars and cycle (Euronews) Click below to see the latest South and South East headlines
